Pliant Therapeutics (PLRX) Interest Coverage Ratio (2022 - 2025)
Pliant Therapeutics (PLRX) reported Interest Coverage Ratio of 173.36 for Q4 2025, down 171.16% year-over-year from 243.62 in Q4 2024, and down 399.8% quarter-over-quarter from 34.69 in Q3 2025.
Pliant Therapeutics (PLRX) Interest Coverage Ratio (2022 - 2025) Analysis & Trends
Pliant Therapeutics (PLRX) has 4 years of Interest Coverage Ratio data on file, last reported at 173.36 in Q4 2025.
- Interest Coverage Ratio for Q4 2025 came in at 173.36, down 171.16% year-over-year; the trailing twelve-month figure through Mar 2026 was 67.73 (up 2.6% YoY), and the FY2025 annual result was 61.11, up 19.08% from the prior year.
- Interest Coverage Ratio slipped to 173.36 in Q4 2025 per PLRX's latest filing, from 34.69 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 34.69 in Q3 2025 and troughed at 173.36 in Q4 2025.
- A 4-year average of 109.1 and a median of 117.73 in 2024 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio jumped 56.37% in 2024, then tumbled 171.16% in 2025.
- A 4-year view of Interest Coverage Ratio shows it stood at 117.98 in 2022, then slipped by 24.2% to 146.53 in 2023, then jumped by 56.37% to 63.93 in 2024, then plunged by 171.16% to 173.36 in 2025.
- Business Quant data shows PLRX's Interest Coverage Ratio at 173.36 in Q4 2025, 34.69 in Q3 2025, and 56.36 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | Pliant Therapeutics | 71.07 Mn | 71.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -173.36 |
| Sep 30, 2025 | -34.69 |
| Jun 30, 2025 | -56.36 |
| Mar 31, 2025 | -73.76 |
| Dec 31, 2024 | -63.93 |
| Sep 30, 2024 | -70.71 |
| Jun 30, 2024 | -69.86 |
| Mar 31, 2024 | -117.73 |
| Dec 31, 2023 | -146.53 |
| Sep 30, 2023 | -150.43 |
| Jun 30, 2023 | -148.36 |
| Mar 31, 2023 | -135.35 |
| Dec 31, 2022 | -117.98 |
| Sep 30, 2022 | -106.14 |
| Jun 30, 2022 | -171.34 |